The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 10)
T-Mobile Agrees To Raise $2B Via Institutional Senior Note Offering For Debt Financing
T-Mobile US Inc’s (NASDAQ:TMUS) subsidiary T-Mobile USA, Inc has agreed to sell $1.3 billion 3.4% Senior Secured Notes due…
BioCryst Stock Jumps After Pulling Out $200M Equity Raise
BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) has withdrawn its proposed public offering of $200 million of its stock and pre-funded warrants. The Company says…
Engine Media Entered At-The-Market Equity Distribution Deal With Canaccord For Issuance Of Up To $50M In Common Shares
Engine Media Holdings, Inc. ("Engine" or the "Company"); (NASDAQ:GAME)(TSXV:GAME), a provider of sports and esports gaming experiences, along with media solutions focused on influencer marketing,
Gates Announces 25M Share Offering By Selling Shareholders
Gates Industrial Corporation plc (NYSE:GTES, ", , Gates", , )))) announced today that certain selling stockholders affiliated with The Blackstone Group Inc. have commenced a secondary offering of 25,000,000 of
RNA Tech Vaccine Developer GreenLight Biosciences Riding To NASDAQ Debut Via $1.5B SPAC Deal
GreenLight Biosciences Inc is combining with a special-purpose acquisition company to go public in a deal that values the…
Uber Raises $1.5B Via Institutional Senior Note Offering To Partly Finance Transplace Acquisition
Uber Technologies (NYSE:UBER) priced $1.5 billion 4.50% Senior Notes due 2029 in a secondary institutional offering. The notes will accrue interest…
First Republic Bank Prices Common Stock Offering Of 2M Shares
First Republic Bank Prices Common Stock Offering
First Republic Bank ("First Republic") (NYSE:FRC), a leading private bank and wealth management company, today announced the pricing of an underwritten public